Inventor · disambiguated record
Khalid M. El-Say
Also filed as: EL-SAY KHALID M · EL-SAY KHALID MOHAMED
11 granted patents·15 citations·filing 2019–2023
84Inventor score
Files withUNIV KING ABDULAZIZ11
Top patents by PatentIndex Score
11 records- 0188US10799455B1Micellles containing alpha lipoic acid as a transdermal drug delivery systemUNIV KING ABDULAZIZ·Filed 2019·Granted Oct 13, 2020·5 cites·7 claims
- 0284US10813882B1In situ gelling formulation for reduced initial drug burstUNIV KING ABDULAZIZ·Filed 2019·Granted Oct 27, 2020·3 cites·3 claims
- 0383US10744137B1Liquisolid tablet containing combined dose of tadalafil and dapoxetineUNIV KING ABDULAZIZ·Filed 2020·Granted Aug 18, 2020·2 cites·13 claims
- 0483US10653634B1Polymeric nanoparticulate formulation to enhance the oral bioavailability of dapoxetineUNIV KING ABDULAZIZ·Filed 2019·Granted May 19, 2020·2 cites·13 claims
- 0582US10736843B1In situ gelling composition containing tocopherol-loaded micelles as an intranasal drug delivery systemUNIV KING ABDULAZIZ·Filed 2019·Granted Aug 11, 2020·2 cites·14 claims
- 0680US11253481B1Self-nanoemulsifying 3D-printed tablet composition and method of use thereofUNIV KING ABDULAZIZ·Filed 2021·Granted Feb 22, 2022·1 cites·9 claims
- 0768US11890380B1Buccal formulation of avanafil with enhanced bioavailability and prolonged durationUNIV KING ABDULAZIZ·Filed 2023·Granted Feb 6, 2024·0 cites·2 claims
- 0868US11648205B1Buccal formulation of avanafil with enhanced bioavailability and prolonged durationUNIV KING ABDULAZIZ·Filed 2022·Granted May 16, 2023·0 cites·3 claims
- 0968US11096902B1Transdermal film formulations and methods of useUNIV KING ABDULAZIZ·Filed 2021·Granted Aug 24, 2021·0 cites·11 claims
- 1053US11298321B1Methods for treating metabolic disorderUNIV KING ABDULAZIZ·Filed 2021·Granted Apr 12, 2022·0 cites·13 claims
- 1150US11185513B1Transfersome-containing transdermal film formulations and methods of useUNIV KING ABDULAZIZ·Filed 2021·Granted Nov 30, 2021·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →